These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 11173178)
1. Effects of physical activity and menopausal hormone replacement therapy on postural stability in postmenopausal women--a cross-sectional study. Brooke-Wavell K; Prelevic GM; Bakridan C; Ginsburg J Maturitas; 2001 Jan; 37(3):167-72. PubMed ID: 11173178 [TBL] [Abstract][Full Text] [Related]
2. The influence of physical activity on the response of bone mineral density to 5 years tibolone. Brooke-Wavell K; Prelevic GM; Bartram C; Ginsburg J Maturitas; 2000 Jun; 35(3):229-35. PubMed ID: 10936739 [TBL] [Abstract][Full Text] [Related]
3. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone. Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347 [TBL] [Abstract][Full Text] [Related]
4. Brisk walking and postural stability: A cross-sectional study in postmenopausal women. Brooke-Wavell K; Athersmith LE; Jones PR; Masud T Gerontology; 1998; 44(5):288-92. PubMed ID: 9693261 [TBL] [Abstract][Full Text] [Related]
5. Postmenopausal HRT and tibolone in relation to muscle strength and body composition. Jacobsen DE; Samson MM; Kezic S; Verhaar HJ Maturitas; 2007 Sep; 58(1):7-18. PubMed ID: 17576043 [TBL] [Abstract][Full Text] [Related]
7. Tibolone low dose (1.25 mg/d) therapy and postural balance in elderly women. Naessen T; Lindmark B; Larsen HC; van Os S; Larsson M Maturitas; 2009 Jan; 62(1):72-5. PubMed ID: 19097714 [TBL] [Abstract][Full Text] [Related]
8. The benefit of hormone replacement therapy on bone mass is greater at the vertebral body than posterior processes or proximal femur. Duan Y; Tabensky A; DeLuca V; Seeman E Bone; 1997 Nov; 21(5):447-51. PubMed ID: 9356739 [TBL] [Abstract][Full Text] [Related]
9. The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis. Anagnostis P; Galanis P; Chatzistergiou V; Stevenson JC; Godsland IF; Lambrinoudaki I; Theodorou M; Goulis DG Maturitas; 2017 May; 99():27-36. PubMed ID: 28364865 [TBL] [Abstract][Full Text] [Related]
11. Comparison of soft tissue body composition in postmenopausal women with or without hormone replacement therapy considering the influence of reproductive history and lifestyle. Dittmar M Ann Hum Biol; 2001; 28(2):207-21. PubMed ID: 11293728 [TBL] [Abstract][Full Text] [Related]
12. The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women. Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Mäenpää PH J Bone Miner Res; 2000 Dec; 15(12):2479-86. PubMed ID: 11127213 [TBL] [Abstract][Full Text] [Related]
13. Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women. Hänggi W; Lippuner K; Jaeger P; Birkhäuser MH; Horber FF Clin Endocrinol (Oxf); 1998 Jun; 48(6):691-9. PubMed ID: 9713556 [TBL] [Abstract][Full Text] [Related]
14. Continuous combined hormone replacement therapy compared with tibolone. Al-Azzawi F; Wahab M; Habiba M; Akkad A; Mason T Obstet Gynecol; 1999 Feb; 93(2):258-64. PubMed ID: 9932566 [TBL] [Abstract][Full Text] [Related]
15. Effects of hormone replacement therapy on muscle performance and balance in post-menopausal women. Armstrong AL; Oborne J; Coupland CA; Macpherson MB; Bassey EJ; Wallace WA Clin Sci (Lond); 1996 Dec; 91(6):685-90. PubMed ID: 8976803 [TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy and risk of falling in early postmenopausal women - a population-based study. Randell KM; Honkanen RJ; Komulainen MH; Tuppurainen MT; Kröger H; Saarikoski S Clin Endocrinol (Oxf); 2001 Jun; 54(6):769-74. PubMed ID: 11422111 [TBL] [Abstract][Full Text] [Related]
18. The influence of hormone replacement therapy (HRT) on serum leptin concentration in postmenopausal women. Hadji P; Görke K; Hars O; Bauer T; Emons G; Schulz KD Maturitas; 2000 Dec; 37(2):105-11. PubMed ID: 11137329 [TBL] [Abstract][Full Text] [Related]
19. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Norman RJ; Flight IH; Rees MC Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730 [TBL] [Abstract][Full Text] [Related]
20. Moderate physical activity is associated with higher bone mineral density in postmenopausal women. Hagberg JM; Zmuda JM; McCole SD; Rodgers KS; Ferrell RE; Wilund KR; Moore GE J Am Geriatr Soc; 2001 Nov; 49(11):1411-7. PubMed ID: 11890577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]